Centene Corp Reports Director and Officer Changes

Ticker: CNC · Form: 8-K · Filed: 2025-08-04T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

TL;DR

Centene's board and execs are changing, filing shows.

AI Summary

Centene Corporation filed an 8-K on August 4, 2025, reporting events as of August 1, 2025. The filing pertains to the departure of directors, election of directors, appointment of officers, and compensatory arrangements for certain officers. Specific details regarding these changes were not provided in the excerpt.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.

Risk Assessment

Risk Level: low — The filing reports routine corporate governance changes without immediate financial implications.

Key Players & Entities

FAQ

What specific changes occurred regarding Centene Corporation's directors and officers?

The filing indicates the departure of directors, election of directors, and appointment of certain officers, as well as details on compensatory arrangements, but the specific names and details are not provided in this excerpt.

When were the reported events effective?

The earliest event reported was effective as of August 1, 2025.

What is Centene Corporation's state of incorporation?

Centene Corporation is incorporated in Delaware.

What is the SEC file number for Centene Corporation?

The SEC file number for Centene Corporation is 001-31826.

Where are Centene Corporation's principal executive offices located?

Centene Corporation's principal executive offices are located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105.

From the Filing

0001071739-25-000155.txt : 20250804 0001071739-25-000155.hdr.sgml : 20250804 20250804163648 ACCESSION NUMBER: 0001071739-25-000155 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250801 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250804 DATE AS OF CHANGE: 20250804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 251180915 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20250801.htm 8-K cnc-20250801 0001071739 false 0001071739 2025-08-01 2025-08-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS (b)    On August 1, 2025, Director Wayne S. DeVeydt notified Centene Corporation (the Company) of his resignation, effective immediately. Mr. DeVeydt's resignation was not the result of any dispute or disagreement with the Company or the Company's Board of Directors (the Board) on any matter relating to the operations, policies or practices of the Company. Effective as of Mr. DeVeydt's resignation, the Board reduced the number of directors constituting the Board to ten directors. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registran

View on Read The Filing